On Friday 15 March 2013 Ark Therapeutics Group plc announced that it had sold its operating subsidiaries, including Ark Therapeutics Limited, to WKD Holding Oy. The new owners can be contacted on (London: +44 (0)207 388 7722); Finland: +358 17 240 875)